Olema Pharmaceuticals (OLMA) Times Interest Earned (2020)

Olema Pharmaceuticals (OLMA) reported Times Interest Earned of -$1.6 for Q1 2020.

Olema Pharmaceuticals (OLMA) Times Interest Earned (2020) Analysis & Trends

Olema Pharmaceuticals (OLMA) has 1 years of Times Interest Earned data on file, last reported at -$1.6 in Q1 2020.

  • Times Interest Earned for Q1 2020 came in at -$1.6, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was -$32.97 (changed N/A YoY), and the FY2020 annual result was -$32.97, changed N/A from the prior year.
  • Times Interest Earned was little changed at -$1.6 in Q1 2020 per OLMA's latest filing.
  • Over five years, Times Interest Earned peaked at -$1.6 in Q1 2020 and troughed at -$1.6 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 3.58
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -258.33
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 11.50
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 547.67
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - 11.79
10 Olema Pharmaceuticals 1.01 Bn 1.01 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -1.60